Opendata, web and dolomites

HIL PT System SIGNED

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HIL PT System project word cloud

Explore the words cloud of the HIL PT System project. It provides you a very rough idea of what is the project "HIL PT System" about.

private    initial    ultra    simplicity    iba    150    machine    investment    magnets    tremendous    additional    1930    belgium    expensive    software    sized    installation    competitors    relative    patents    2b    contacts    50    company    operation    function    technologies    accessible    clinical    ip    proton    compact    estimates    conjunction       annual    gap    magnetic    hil    sell    construction    requiring    university    intensity    facilities    continues    excess    particle    10m    additionally    germany    feasibility    pt    hospitals    procedure    demand    250m    prohibitively    space    originated    chain    insure    valuable    accelerators    45m    patented    preliminary    solutions    room    accelerator    adoption    size    israel    combining    cosy    acceleration    saving    technological    markets    slovenian    performance    updated    purchase    fast    center    trials    hebrew    world    setup    too    beam    labs    single    market    therapy    labor    jeruslaem    medical    slowly    applies    largely    nano    61    beamline    supply    era    30    breakthroughs    lasers    cancer    massive    save   

Project "HIL PT System" data sheet

The following table provides information about the project.

Coordinator
HIL APPLIED MEDICAL LTD 

Organization address
address: 4/5 HI-TECH PARK, GIVAT RAM
city: JERUSALEM
postcode: 9139000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://hilappliedmedical.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HIL APPLIED MEDICAL LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

HIL Applied Medical is developing ultra-compact, high-performance system for cancer Proton Therapy (PT). HIL’s advanced particle accelerator and beamline technologies aim to make PT widely accessible, thus creating a market potential in excess of $2B/year for HIL. HIL’s technology originated in breakthroughs achieved at the Hebrew University in Jeruslaem, Israel, and is not expected to require clinical trials. Currently there are only 61 operating PT facilities in the world, addressing only 3-5% of the clinical demand. This tremendous demand-supply gap is due to prohibitively expensive construction ($150-250M) and annual operation (~$10M/year) of a PT center. Single-room solutions are slowly becoming available at $30-45M – still too expensive for widespread adoption. Costs are largely the result of 1930’s-era technology – massive, complex particle accelerators and magnets. HIL applies a patented approach to particle acceleration and beam delivery, combining nano-technology with ultra-high-intensity lasers and novel magnetic design. These technological breakthroughs enable meaningful reduction in size of up to 50%, saving hospitals valuable space and requiring less initial investment on setup labor. Additionally, the HIL PT system will function on state of the art software developed by Slovenian software company Cosy Labs to insure simplicity and functionality. Finally, preliminary cost estimates show that the HIL system will allow hospitals to save up to 2/3 on cost of purchase and installation relative to competitors. During the Phase 1 feasibility assessment, in conjunction with partners IBA, HIL Applied will identify specific private hospitals to sell to. Target markets of Germany and Belgium will be sized and contacts established. A supply chain procedure will be established in order to insure fast delivery for machine setup. As R&D continues, additional IP will be updated via patents.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HIL PT SYSTEM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HIL PT SYSTEM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

Gri3D (2018)

The industrialization and market entry of a novel bioengineered hydrogel grid to standardize stem cell cultures for precision medicine.

Read More  

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

NAS (2018)

Nexilis augmentation system

Read More